A Study to Evaluate the Effect of Kushmanda Paneeya Kshara in the Treatment of Benign Prostate Hyperplasia

Randomized Controlled Trial On Efficacy Of Kushmanda Paneeya Kshara In The Management Of Vatasthila With Special Reference To Benign Prostate Hyperplasia. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/104487

Enrollment

Registered

2026-02-23

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms Health Condition 2: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing to participate in study. Patients presenting with clinical features of Vatasthila (BPH) will be selected randomly irrespective of caste, religion and socio-economic status. Patients between the age group of 40 to 75 years. Patients having mild (1 7), moderate (8 19) International Prostate Symptoms Score of Benign Prostate Hyperplasia will be included. Patients having high International Prostate Symptoms Score (20 35) with no other complications of Benign Prostate Hyperplasia and not willing to undergo surgery will be included. Patients with Controlled Diabetes Mellitus. [BSL Random between 70 140 mg/dl] will be included. Co-operative patients.

Exclusion criteria

Exclusion criteria: Patients not willing to participate in the study. Patients below the age of 40 years and above 75 years. Patients having Hematuria. Patients with Uremia, Septicemia, Bladder Outlet Obstruction, Urethral Stricture, Renal Calculi, CA Prostate. Patients with Uncontrolled Diabetes Mellitus [BSL Random above 140 mg/dl] will be excluded. Patient with other major systemic illness which interfere with the treatment will be excluded. Immunocompromised patients. Patients with acute retention of urine who need surgical intervention. Non-co-operative patients.

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of Kushmanda Paneeya Kshara in the management of Vatasthila with special reference to Benign Prostate Hyperplasia. To evaluate the efficacy of Patala Kshara in the management of Vatasthila with special reference to Benign Prostate Hyperplasia. To compare the efficacy of Kushmanda Paneeya Kshara and Patala Kshara in the management of Vatasthila with special reference to Benign Prostate Hyperplasia.Timepoint: Follow up on 5th 10th and 15th day	—

Measure

Time frame

To evaluate the efficacy of Kushmanda Paneeya Kshara in the management of Vatasthila with special reference to Benign Prostate Hyperplasia. To evaluate the efficacy of Patala Kshara in the management of Vatasthila with special reference to Benign Prostate Hyperplasia. To compare the efficacy of Kushmanda Paneeya Kshara and Patala Kshara in the management of Vatasthila with special reference to Benign Prostate Hyperplasia.Timepoint: Follow up on 5th 10th and 15th day

—

Secondary

Measure	Time frame
To study the effects on various symptoms of Benign Prostate Hyperplasia. To study the literature regarding Vatasthila & Benign Prostate Hyperplasia.Timepoint: Follow up on 5th 10th & 15th day	—

Countries

India

Contacts

Public ContactDr Nita Kedar

Government Ayurved College and Hospital

drnita6@gmail.com9422117613

Outcome results